NFE2L2 and cancer: Similarly, some research reported that miR-155 was oncogenic in several cancers through targeting Nrf2-mediated OS [153–155], which was considered as a promising biomarker coupled with telomerase reverse transcriptase (TERT) in a clinical exploration through assessing the potential roles in the diagnosis of non-muscle-invasive bladder cancer and their correlation with stage and grade (NCT03591367).